Clinical Trial Update: Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

View source ↗

Summary

An ongoing clinical trial by Paragonix Technologies aims to create a global registry to improve donor lung preservation. Enrollment is by invitation and covers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Cystic Fibrosis
• Emphysema
• Interstitial Lung Disease
• Pulmonary Arterial Hypertension
• Pulmonary Fibrosis

Snippet

Sponsor: Paragonix Technologies | Conditions: Interstitial Lung Disease, COPD | Status: ENROLLING_BY_INVITATION